
    Original Text: Evidence of bleeding diathesis or clinically significant coagulopathy (in the absence of therapeutic anticoagulation); any history of significant bleeding or thrombosis should be discussed with the study principal investigators (PIs)
    Disease/Condition: none
    Procedure: Bleeding Diathesis, Coagulopathy
    Drug: none
    Biomarker: none
    Computable Rule: "Evidence of bleeding diathesis or clinically significant coagulopathy (in the absence of therapeutic anticoagulation)" AND NOT ("any history of significant bleeding or thrombosis should be discussed with the study principal investigators (PIs)")

Criterion:
    Patients with a history of malignancy other than non-melanoma skin cancer within the last 5 years

Output:
    Original Text: Patients with a history of malignancy other than non-melanoma skin cancer within the last 5 years
    Disease/Condition: none
    Procedure: Malignancy
    Drug